IMNN · Company research
Imunon, Inc. (IMNN): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
17records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Stock replaces cash salary as Imunon (IMNN) chairman acquires 7,800 shares at $1.08 each. - Stock Titan | Stock replaces cash salary as Imunon (IMNN) chairman acquires 7,800 shares at $1.08 each. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| Imunon (IMNN) grants its CEO 2,977 shares in lieu of cash for part of her base salary. - Stock Titan | Imunon (IMNN) grants its CEO 2,977 shares in lieu of cash for part of her base salary. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| At $1.08 a share, Imunon (IMNN) grants its medical chief 1,249 shares in place of cash salary. - Stock Titan | At $1.08 a share, Imunon (IMNN) grants its medical chief 1,249 shares in place of cash salary. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| Imunon, Inc. (IMNN) Stock Price, News, Quote & History - Yahoo! Finance Canada | Imunon, Inc. (IMNN) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 9, 2026 | neutral | 0 | 0.6 |
| Imunon Inc (NASDAQ: IMNN) Share Price, IMNN Stock News, IMNN Share Price & Updates - Kalkine | Imunon Inc (NASDAQ: IMNN) Share Price, IMNN Stock News, IMNN Share Price & Updates Kalkine | View source ↗ | Kalkine | Oct 2, 2026 | neutral | 0 | 0.6 |
| Imunon Introduces Series B Preferred to Restructure Debt - The Globe and Mail | Imunon Introduces Series B Preferred to Restructure Debt The Globe and Mail | View source ↗ | The Globe and Mail | Sep 30, 2026 | neutral | 0 | 0.6 |
| A debt swap cuts IMUNON’s outstanding debt by about 43%, with no common shares issued. - Stock Titan | A debt swap cuts IMUNON’s outstanding debt by about 43%, with no common shares issued. Stock Titan | View source ↗ | Stock Titan | Sep 29, 2026 | neutral | 0 | 0.6 |
| At $1.41 a share, Imunon (IMNN) granted its medical chief 4,390 shares in place of part of his cash salary. - Stock Titan | At $1.41 a share, Imunon (IMNN) granted its medical chief 4,390 shares in place of part of his cash salary. Stock Titan | View source ↗ | Stock Titan | Sep 28, 2026 | neutral | 0 | 0.6 |
| Imunon Inc. (IMNN) Shares Edge Higher to $1.43 as Stock Presses Against $1.50 Resistance - Low Vol Factor - https://www.siam.in/ | Imunon Inc. (IMNN) Shares Edge Higher to $1.43 as Stock Presses Against $1.50 Resistance - Low Vol Factor https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Sep 28, 2026 | neutral | 0 | 0.6 |
| A 7,169-share salary award leaves Imunon (IMNN) chair with 103,921 shares held directly. - Stock Titan | A 7,169-share salary award leaves Imunon (IMNN) chair with 103,921 shares held directly. Stock Titan | View source ↗ | Stock Titan | Sep 28, 2026 | neutral | 0 | 0.6 |
| Imunon, Inc. (IMNN) Shareholder/Analyst Call - Slideshow (NASDAQ:IMNN) 2026-09-24 - Seeking Alpha | Imunon, Inc. (IMNN) Shareholder/Analyst Call - Slideshow (NASDAQ:IMNN) 2026-09-24 Seeking Alpha | View source ↗ | Seeking Alpha | Sep 24, 2026 | neutral | 0 | 0.6 |
| A patient in an ovarian cancer trial reports no recurrence nearly 10 years after diagnosis - Stock Titan | A patient in an ovarian cancer trial reports no recurrence nearly 10 years after diagnosis Stock Titan | View source ↗ | Stock Titan | Sep 24, 2026 | neutral | 0 | 0.6 |
| IMUNON Enters CRADA with NCI’s CTEP to Advance IMNN-001 in New Cancer Indications and Combinations - Quiver Quantitative | IMUNON Enters CRADA with NCI’s CTEP to Advance IMNN-001 in New Cancer Indications and Combinations Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 10, 2026 | neutral | 0 | 0.6 |
| IMUNON reports $2.8 million Q2 loss as OVATION 3 enrollment advances | IMNN Stock News - Quiver Quantitative | IMUNON reports $2.8 million Q2 loss as OVATION 3 enrollment advances | IMNN Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 11, 2026 | neutral | 0 | 0.6 |
| Imunon, Inc. (IMNN) Presents at Life Sciences Virtual Investor Forum - Slideshow (NASDAQ:IMNN) 2026-06-26 - Seeking Alpha | Imunon, Inc. (IMNN) Presents at Life Sciences Virtual Investor Forum - Slideshow (NASDAQ:IMNN) 2026-06-26 Seeking Alpha | View source ↗ | Seeking Alpha | Jun 26, 2026 | neutral | 0 | 0.6 |
| IMNN Forecast — Price Target — Prediction for 2027 - TradingView | IMNN Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Imunon Secures $10 Million Financing From Streeterville Capital; Issues Preferred Stock and Notes - TradingView | Imunon Secures $10 Million Financing From Streeterville Capital; Issues Preferred Stock and Notes TradingView | View source ↗ | TradingView | Jun 4, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.